Off-Label Convictions Of Device Execs Could Impact Pharma Sales Reps
Executive Summary
Jury acquits former executives from J&J's Acclarent division of felony charges but convicts them on misdemeanor counts for marketing a sinus dilation device for use with a steroid; sales reps statements showed intended use.
You may also be interested in...
Pharma Deals With The DOJ
A look at the settlement agreements pharma companies have struck with the Department of Justice in the last three years; the size of the deals has declined dramatically since 2012.
Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors
Off-label marketing and kickbacks may no longer be the top targets of government healthcare fraud investigations as more companies are being hit with subpoenas for pricing information.
Acquittal Of Former Warner Chilcott Exec May Make Future Prosecutions More Difficult
Boston jury clears Carl Reichel of conspiring to pay kickbacks to physicians in case involving dinners and speaker fees.